About Us
SQ Innovation, Inc. (SQI) is a privately held Swiss biopharmaceutical company located in Zug, Switzerland, and Burlington, Massachusetts, United States.
SQI was established in 2019 to develop and commercialize innovative cost-effective therapies for subcutaneous delivery of pharmaceutical products.
Device innovation is our space. This is why we named the company SQ Innovation. We are committed to bringing innovative devices to the market that are of high-quality, affordable and feature rich.
Our first product, Lasix® SQF, is a subcutaneous Infusor for the treatment of fluid overload (edema) in patients with heart failure. It is currently under development and is not yet approved by the U.S. FDA.
Our Mission
We develop and manufacture innovative, quality combination products that are safe and effective.
Our Quality Policy
We are committed to meeting customer expectations and regulatory requirements; to develop and manufacture innovative high quality combination products, and to continually improve our processes and products.
Our Values
Trust
We provide dependable products that meet customer expectations and improve patient care
Talent
We value our people and their contributions towards operational excellence.
Innovation
We aim to design and develop transformative products for the benefit of patients and society.
Collaboration
We partner with leading contract manufacturers and suppliers to produce safe and effective products.